Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001493152-24-012069

Options or other derivatives

  • Chief Financial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Arrow Alexander K. Chief Financial Officer 2024-03-25 Grant or award · PTIX Common stock Options +100,000 $1.74 $174,000 100,000 D
Loading xslF345X05/ownership.xml…